Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Ryan V. Hartwell | M | - |
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | - |
Mark S. Miller | M | - |
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | - |
Susan M. Elliott | F | - |
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | - |
Joseph Sardano | M | 71 |
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | 6 ans |
Teresa Bair | F | 53 |
BirchBioMed, Inc.
BirchBioMed, Inc. Pharmaceuticals: MajorHealth Technology BirchBioMed, Inc. operates as a clinical-stage biomedical company. It focuses on the clinical evaluation, development, and commercialization of anti-scarring drugs, autoimmune therapeutics and novel strategies for transplantation. The company was founded by Mark S. Miller, Ryan V. Hartwell and Susan M. Elliott and is headquartered in King City, Canada. | 5 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
Pays | Relations | % du total |
---|---|---|
Canada | 5 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Charles N. Ellis
- Réseau Personnel